TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

Cited by (657)

Items 501–600 of 657

  1. Spatiotemporal dynamics of radioresistance: decoding macrophage-driven radioprotective niches through temporal-spatial reprogramming
    Miao Zhang, Xueli Zhang, Xueyi Song, Ruixue Bai, Qiao Qiao, Minjie Wei, Lin Zhao · 2026 · Molecular Cancer
  2. High-throughput fragment screening identifies a new small molecule scaffold that modulates TREM2 Signaling.
    Natalie Fuchs, F. El Gaamouch, H. Nada, Sungwoo Cho, M. Gabr · 2026 · Bioorganic & Medicinal Chemistry
  3. Hierarchical Targeting of TREM2 + Myeloid Cells via Acid‐Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone‐Metastatic TNBC
    Fanglu Chen, Yucheng Xue, Xiao Ma, Liang Chen, Zhenxuan Shao, Hangxiang Sun, Haochen Mou, Fang Wang, Zilong Li, Yechao Shen et al. · 2026 · Advanced Science
  4. Cell-based cancer immunotherapy: milestones, mechanistic insights, and emerging therapeutic directions
    Ji-zhao Cao, wei zhao, Xiao‐Jun Xia · 2026 · Acta Pharmacologica Sinica
  5. Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy
    Anna Rita Redavid, Loredana Cifaldi, Roberto Bei, Emmanuel de Billy, Doriana Fruci · 2026 · Journal for ImmunoTherapy of Cancer
  6. Single-cell profiling of gastric cancer ascites reveals an epithelial-immune dual phenotype signature predictive for anti-PD-1 immunotherapy responses
    Tianbing Xu, Muyang Yang, Jing Huang, Lisen Lu, Deqiang Deng, Xiujuan Shi, Yao Sun, Jonathan F. Lovell, Z.B Lin, Y B Zheng et al. · 2026 · BMC Medicine
  7. Metabolic reprogramming of myeloid cells in cancer: from lactate–NAMPT axis to AI-guided therapeutics
    In-Gu Lee, Keehoon Jung · 2026 · Experimental & Molecular Medicine
  8. Revisiting TREM2: from multi-omics signaling networks to clinical translation
    Jing Yang, Dehong Wan, Lina Ren, Yaqing Lv, Hai Zhao · 2026 · Frontiers in Immunology
  9. TREM2 as a Prognostic Biomarker for Osteosarcoma Microenvironment Remodeling
    Zhilong Zestel Shen, Zhao-Yu Chen, Yong Ji, Hao Jiang, Zhi-Peng Zhu, Hao Yuan, Bo Li, Wei Xu, Jianru Xiao · 2023 · Journal of Oncology
  10. Gammaherpesvirus Infection Stimulates Lung Tumor-Promoting Inflammation
    Sudurika Mukhopadhyay, Kenneth F. Swan, Gabriella C. Pridjian, Jay K. Kolls, Yan Zhuang, Qinyan Yin, Joseph A. Lasky, Erik F. Flemington, Cindy A. Morris, Zhen Nan Lin et al. · 2024 · Pathogens
  11. Revolutionizing prognostic predictions in colorectal cancer: Macrophage‑driven transcriptional insights from single‑cell RNA sequencing and gene co‑expression network analysis
    Yang Feng, Zhuo Cheng, Jingyuan Gao · 2024 · Oncology Letters
  12. CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
    Eric Gustav Carlson, Jennifer C. Lopez, Yukiko Yamaguchi, Jackson Gibson, Saul J. Priceman, Mark A. LaBarge · 2025 · Breast Cancer Research
  13. Targeting TREM2 to enhance immunotherapy
    Sarah Crunkhorn · 2020 · Nature Reviews Drug Discovery
  14. Construction and Evaluation of an M2 Macrophage-Related Prognostic Model for Colon Cancer
    Min Ji, Yanping Chen, Lu Zhang, Leqian Ying, Chunchun Huang, Lin Liu · 2023 · Applied Biochemistry and Biotechnology
  15. Gadolinium-based nanoparticles AGuIX and their combination with ionizing radiation trigger AMPK-dependent proinflammatory reprogramming of tumor-associated macrophages
    Zeinaf Muradova, Désirée Tannous, Ali Mostefa-Kara, Thanh Trang Cao-Pham, Constance Lamy, Sophie Broutin, Angélo Paci, Sandrine Dufort, Tristan Doussineau, François Lux et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Host-derived Interleukin 1α induces an immunosuppressive tumor microenvironment via regulating monocyte-to-macrophage differentiation
    M. K. Raja, Gourab Gupta, Grace Atkinson, Katie L. Kathrein, A. Armstrong, M. Gower, Igor B. Roninson, Eugenia V Broude, Meng-Qian Chen, Hao Ji et al. · 2024 · bioRxiv
  17. A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells
    Thomas Welte, Junhua Mai, Zhe Zhang, Shaohui Tian, Guodong Zhang, Yitian Xu, Licheng Zhang, Shu-shia Chen, Tian Wang, Haifa Shen · 2021 · iScience
  18. Single‐Nucleus RNA Sequencing Reveals That Gabra6 + Neurons in Prefrontal Cortex Promote the Progression of PTSD After Shockwave‐Induced TBI
    Xiaowei Fei, Zehan Zhang, Yanan Dou, Weihao Lv, Hongqing Chen, Li Wang, Xin He, Wangshu Chao, Peng Luo, Zhou Fei · 2024 · Advanced Science
  19. PKCδ Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells
    Kyle R. Cron, Ayelet Sivan, Keston Aquino-Michaels, Andrea Ziblat, Emily F. Higgs, Randy F. Sweis, Ruxandra Tonea, Seoho Lee, Thomas Frank Gajewski · 2025 · Cancer Immunology Research
  20. One Step Ahead: Preventing Tumor Adaptation to Immune Therapy
    Erica Lynne Braverman, Giuliana P. Mognol, Andy J. Minn, Dario A.A. Vignali, Judith A. Varner · 2025 · American Society of Clinical Oncology Educational Book
  21. Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
    Dimitrios Papakonstantinou, Haiding Wang, Mohamed Amine Bani, Kevin Mulder, Garett Dunsmore, Alice Boilève, Gérôme Jules-Clément, Leonardo G. Panunzi, Leslie Robert de Sousa, Carlos de la Calle‐Fabregat et al. · 2025 · Cancer Treatment and Research Communications
  22. Discovery of EP4 antagonists with image-guided explainable deep learning workflow
    Pengsen Ma, Zhiyuan Cheng, Zhixiang Cheng, Yijie Wang, Xiaolei Chai, Bo Feng, Hongxin Xiang, Li Zeng, Xueming Liu, Pengyong Li et al. · 2025 · National Science Open
  23. Targetable axes of tumor-associated macrophages: An MSF framework for precision immunotherapy
    Zhaohui Lu, Midie Xu, Junzhe Tang, Xinyi Wang, Xinxiang Li, Qingguo Li · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  24. TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer
    Elysa W. Pierro, Guadalupe Garcia, Violeta Sanchez, P. González-Ericsson, Barbara Fingleton, Alyssa H. Hasty, B. Rexer · 2025 · Scientific Reports
  25. Neuroinflammatory markers sTREM2 and YKL-40 in association with Alzheimer’s disease pathology: a systematic review and meta-analysis
    Rachael Yu, Anastasia S. Suraev, Victor Vidal, Shawn Dexiao Kong, Robert Hugh Zachariae, Laura M. Piccio, Michael Thomas Heneka, Sharon Linda Naismith, Johannes C. Michaelian · 2026 · Molecular Psychiatry
  26. Protumor Macrophage Polarization Mediated by BMP2/4–ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation
    Mingchao Wang, Zhihong Song, Hao Yuan, Chang Liu, Wei Wang, Naixue Yang, Keyong Sun, Shanshan Zhang, Xuyang Qin, Jingwei Li et al. · 2025 · Cancer Research
  27. Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas
    Silvia Pomella, Roberto Bei, Ombretta Melaiu · 2026 · International Journal of Molecular Sciences
  28. TREM2 in Macrophages Promotes Renal Fibrosis via Activation of β‐Catenin Signalling Pathway in Obstructive Nephropathy
    Jia Wei, Zixia Li, Gengyu Du, Ting Chen, Min Yang, Zhen Yuan, Yidan Zheng, Xiang Yan · 2026 · Cell Proliferation
  29. TAMs in the Gynecological Tumor Microenvironment: Insights from Cross-Cancer Studies for Immunotherapy
    Ruixi Li, Hanyue Liang, Hao Chen, Runjia Weng, Quan Ding, Ziqiu Cai, Shuyi Wang, Yulin Li · 2026 · Cancers
  30. Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma
    Yawei Ding, Kaifeng Jin, Xiaohe Su, Lingkai Zhang, Zhaopei Liu, Jiaxing Sun, Yuzhen Wu, Shi Jinming, Han Zeng, Hailong Liu et al. · 2026 · Journal for ImmunoTherapy of Cancer
  31. Immunotherapy and Hepatocellular Carcinoma: From Tumor-Immune Cell Interactions to Rational Therapeutic Strategies
    Kizuki Yuza, Timothy Michael Pawlik · 2026 · Cells
  32. Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design
    George Nageeb, Joseph H. Ha, Justin Liu, Marcus Sjöholm, Michael K. Lim · 2026 · Neurotherapeutics
  33. Macrophage-directed therapeutic strategies in cancer
    Shweta Joshi, Judith A. Varner · 2026 · Trends in cancer
  34. Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy
    Mengqi Liu, Jiawei Zhang, Jianwei Zhu · 2023 · Pharmaceutical Fronts
  35. Tumor-Associated Macrophages in Colorectal Cancer
    Cornelia Amălinei, Constantin Aleodor Costin, Adriana Grigoraş, Mariana-Bianca Chifu, Diana Lavinia Pricope · 2024 · Interdisciplinary cancer research
  36. Unrestrained cancer immunity ignites atherosclerosis
    Jesse W. Williams, Esther Lutgens · 2024 · Nature Cardiovascular Research
  37. Integration of single-cell RNA and protein data identifies novel clinically-relevant lymphocyte phenotypes in breast cancers
    Ghamdan Al‐Eryani, Nenad Bartoniček, Chia‐Ling Chan, Alma Anderson, Kate Harvey, Sunny Z. Wu, Dan Roden, Taopeng Wang, John Reeves, Bertrand Z. Yeung et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  38. A comprehensive single-cell atlas of freshly-dissociated human synovium in inflammatory arthritis with an optimized dissociation protocol for prospective fresh synovial biopsy collection
    Sam G. Edalat, Reto Gerber, Miranda Houtman, Tadeja Kuret, Nadja Ižanc, Raphael Micheroli, Kristina Buerki, Blaž Burja, Chantal Pauli, Žiga Rotar et al. · 2022 · Research Square
  39. Identification of novel myeloid-derived cell states with implication in cancer outcome
    Gabriela Rapozo Guimarães, Giovanna Resk Maklouf, Cristiane Esteves Teixeira, Leandro de Oliveira Santos, Nayara Gusmão Tessarollo, Marco Antônio M. Pretti, Nayara Evelin de Toledo, Jéssica Gonçalves Vieira da Cruz, Marcelo Falchetti, Mylla M. Dimas et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Targeting Myeloid Protein Kinase C Signaling to Overcome Immune Suppression and Improve Immunotherapy in Cancer
    Mehdi Chaib · 2022
  41. TREM2 Recognition of Candidalysin Orchestrates Mucosal Immunity in Oropharyngeal Candidiasis
    Weiwei Deng, Yishan Chen, Siqi Liu, Kefan Lin, Kai Zhang, Di Wang, Zhiying Yu, Weijia Zhao, Yingping Xu, Xiaowen Wang et al. · 2024 · Research Square
  42. Trem2 deficiency attenuates breast cancer tumor growth in lean, but not obese or weight loss, mice and is associated with alterations of clonal T cell populations
    Elysa W. Pierro, M. Cottam, Hanbing An, B. D. Lehmann, J. Pietenpol, K. Wellen, Liza Makowski, J. Rathmell, Barbara Fingleton, Alyssa H. Hasty · 2024 · bioRxiv
  43. Single cell spatial transcriptomics identifies coordinated cellular programs associated with good prognosis in microsatellite stable colorectal cancer
    Victoria T. Karlsen, Umair Majid, Håvard T. Lindholm, Sinan U. Umu, Karoline Rapp Vander-Elst, Ann-Christin Røberg Beitnes, Marianne A. Merok, Kjersti Thorvaldsen Hagen, Hogne Røed Nilsen, Sheraz Yaqub et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Integrated Analysis of Single-Cell and Bulk RNA-Seq Data reveals that Ferroptosis-Related Genes Mediated the Tumor Microenvironment predicts Prognosis, and guides Drug Selection in Triple-Negative Breast Cancer
    Xuantong Gong, Lishuang Gu, Di Yang, Yu He, Qian Li, Hao Qin, Yong Wang · 2025 · eLife
  45. TREM2 macrophages are associated with enhanced response to PD-1 blockade in human hepatocellular carcinoma
    Pauline Hamon, Matthew D. Park, Jessica Le Bérichel, Merav Cohen, Brian Y. Soong, Mark Buckup, Clotilde Hennequin, Katherine E. Lindblad, Raphaël Mattiuz, Igor Figueiredo et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Divergent role of CD8 T cells with distinct metabolic phenotypes during curative radio-immunotherapy in hot versus cold tumors
    Alexa R. Heaton, Nathaniel J. Burkard, Anqi Gao, Anna Hoefges, Arika S. Feils, Samantha K. Burkard, Mildred A. R. Felder, Noah W. Tsarovsky, Daniel V. Spiegelman, Garrett M. Lublin et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Identification, Characterization, and Targeting of a Rare and Temporal Dendritic Cell State that Facilitates Adaptive Immune Responses
    Peter Deak, Bradley Studnitzer, Rachel C. Steinhardt, Aaron Palmer Esser-Kahn · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  48. The immunoregulation of autoimmune diabetes
    Hao Hu · 2021 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  49. Diseño de una interfaz gráfica para la simulación mediante diferencias finitas
    Sara Sainz-Pardo Martí · 2014
  50. PROGRESS OF ORGANISMS HEALTH & INTELLIGENCE VIA NANITES & REAL-TIME MONITORING OF THEM VIA WIRELESS NETWORKS & MECHATRONIC SYSTEMS
    Chaideftos Chaideftos · 2020 · OSF Preprints (OSF Preprints)
  51. Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and rewires the microenvironment toward an immune-suppressive state
    Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  52. Interleukin-1α and Leukemia Inhibitory Factor Promote Extramedullary Hematopoiesis
    Derek A. G. Barisas, Minseo Kim, Madhav Subramanian, Ashraf Ul Kabir, Karen Krchma, Jun Wu, Bernd H. Zinselmeyer, Colin L. Stewart, Kyunghee Choi · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  53. A Novel Prognostic Model for Hepatocellular Carcinoma Patients Based on Signature Ferroptosis-Immune Microenvironment-Related Genes
    Xisheng Yin, Jiayi Tang, Qian Yang, Ke Xu, Shi Chen, Miao He, Yuhan Yang, Jincheng Luo, Yunyue Li, Xiaoyu Wang et al. · 2022 · Research Square
  54. Data from Characterizing Macrophage Diversity in Metastasis-Bearing Lungs Reveals a Lipid-Associated Macrophage Subset
    Danielle N. Huggins, Rebecca S. LaRue, Ying Wang, Todd Philip Knutson, Yingzheng Xu, Jesse W. Williams, Kathryn L. Schwertfeger · 2023
  55. Data from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts
    Anuja Sathe, Kaishu Mason, Susan M. Grimes et al. · 2023
  56. Data from Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition
    Larissa S. Carnevalli, Molly A. Taylor, Matthew King et al. · 2023
  57. Remodeling Methods of TIME for Enhanced Immunotherapy against Non-Melanoma Skin Cancer
    Arooba Farman Farman · 2023 · Iranian Journal of Blood and Cancer
  58. BBB Dysfunction Defines the Aging Myeloid Landscape Favoring Immune Evasion for Glioma and Alzheimer's Disease
    Ricardo Gargini, Berta Segura‐Collar, Lucía Mondéjar-Ruescas, María Garranzo‐Asensio, Pablo Mata-Martínez, Ramón García‐Escudero, Aurelio Hernández‐Laín, Juan Manuel Sepúlveda-Sánchez, Ángel Pérez‐Núñez, Jesús Ávila et al. · 2023 · Research Square
  59. CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy
    Julia Dallmann, J. Freitag, C. Jung, Krutika Khinvasara, L. Merz, D. Peters, M. Schork, Jan David Beck · 2023 · Immuno-Oncology Technology
  60. TIM-3 blockade as a therapeutic approach for diffuse intrinsic pontine glioma
    Ausejo-Mauleón, I. (Iker) · 2023 · Deposito Adademico Digital Universidad De Navarra (University of Navarra)
  61. An ALK1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases
    Mehrnaz Safaee Talkhoncheh, Jonas Sjölund, Paulina Bolívar, Ewa Kurzejamska, Eugenia Cordero, Teia Vallès Pagès, Sara Larsson, Sophie Lehn, Gustav Frimannsson, Viktor Ingesson et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  62. ER stress-induced TREM2 downregulation exacerbates platelet activation and myocardial infarction in patients with coronary artery disease
    Xiaowen Wu, Guanxing Pan, Lin Chang, Yulong Zhang, Yangyang Liu, Wei Zhang, Yifan Guo, Ge Zhang, Haoxuan Zhong, Zhiyong Qi et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Re-programming by a six-factor-secretome in the patient tumor ecosystem during nutrient stress and drug response
    M. Tarek Elghetany, Jie-Ling Pan, Karthik Sekar, Angela M. Major, Jack M. F. Su, Adekunle M. Adesina, Kam Man Hui, Xiao‐Nan Li, Wan‐Yee Teo · 2024 · iScience
  64. Single-cell transcriptomics reveals the landscape of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy and the potential resistance role of LGALS1
    Qihang Yan, Wuguang Chang, Zhenguo Li, Wingshing Wong, Li Gong, Dachuan Liang, Jie Yang, Shuqin Dai, Junye Wang · 2024 · Research Square
  65. Integrated Analysis of Single-Cell and Bulk RNA-Seq Data reveals that Ferroptosis-Related Genes Mediated the Tumor Microenvironment predicts Prognosis, and guides Drug Selection in Triple-Negative Breast Cancer
    Xuantong Gong, Lishuang Gu, Di Yang, Yu He, Qian Li, Hao Qin, Yong Wang · 2024 · eLife
  66. Cell-Guided Drugs
    Haoyue Qin, Guowei Zhou · 2024 · Springer eBooks
  67. Biomechanical regulation of anti-tumor immune responses in the TME
    Kelly Kersten, Valerie Marie Weaver · 2024 · Elsevier eBooks
  68. Immune memory shapes ovarian cancer recurrence
    Analisa V. DiFeo · 2025 · Cancer Cell
  69. Spatial clustering of immunosuppressive macrophages in papillary renal cell carcinoma
    Mitchell T. Hayes, José Laborde, Alex C. Soupir, Anders Berglund, Jamie K. Teer, Kirill Sabitov, Nicholas Haig Chakiryan, Taylor C. Peak, Jonathan V. Nguyen, Carlos Moran Segura et al. · 2025 · Kidney Cancer
  70. Metabolic Immunosuppression Mediated by Proliferative CD168 + TAMs in Colon Cancer
    Zhihao Wei, Yan Dong, Ruiyang Zi, Taorui Liu, Yahan Fan, Rui Zhang, Yongning Shang, Haoran Jiang, Xiang Zhao, Jianjun Li · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Bhlhe40 Governs T Cell Effector Differentiation with Distinct Requirements in CD4 and CD8 T Cells for Anti-PD-1 and Anti-CTLA-4 Efficacy
    Akata Saha, Tomoyuki Minowa, Alexander S. Shavkunov, Avery J. Salmon, Sunita Keshari, Suresh Satpati, Nicholas N. Jarjour, Abhinav K. Jain, Kunal Rai, Kristen E. Pauken et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Attack cancer: Through autophagic modulations as suppressor or promoter
    Pratishtha Gupta, Shama Parveen, Saurabh Kumar, Ana Ahtsham, Monisha Banerjee · 2025 · World Journal of Clinical Oncology
  73. Deciphering Tumor Microenvironment Dynamics in Tumorigenesis and Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma using Single-cell RNA Sequencing
    H. K. Na, Tae Hee Hong, Chung Lee, Young Ho Yang, Ha Eun Kim, Byung Jo Park, Hyun Ki Kim, Dae Joon Kim · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Additional file 1 of Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
    Mei, Shenglin, Adele M. Alchahin, Ιωάννα Τσέα, Youmna Sami Kfoury, Taghreed Hirz, Nathan Elias Jeffries, Zhao, Ting, Yanxin Xu, Zhang, Hanyu, Sarkar, Hirak et al. · 2024 · Figshare
  75. Additional file 1 of Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways
    Yunji Yan, Bai, Shengwei, Hongxi Han, Dai, Junqiang, Liang Niu, Wang, Hongyu, Dong, Qiang, Hang Yin, Guoqiang Yuan, Pan, Yawen · 2024 · Figshare
  76. Additional file 2 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
    Hui Qiu, Shao, Zhiying, Wen, Xin, Debao Qu, Liu, Zhengyang, Ziqin Chen, Zhang, Xinyan, Ding, Xin, Longzhen Zhang · 2024 · Figshare
  77. Additional file 1 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
    Hui Qiu, Shao, Zhiying, Wen, Xin, Debao Qu, Liu, Zhengyang, Ziqin Chen, Zhang, Xinyan, Ding, Xin, Longzhen Zhang · 2024 · Figshare
  78. Additional file 1 of Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
    Chen, Jian, Tianchuan Zhu, Jiang, Guanmin, Zeng, Qi, Li, Zhijian, Huang, Xi · 2023 · Figshare
  79. Additional file 4 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
    Hui Qiu, Shao, Zhiying, Wen, Xin, Debao Qu, Liu, Zhengyang, Ziqin Chen, Zhang, Xinyan, Ding, Xin, Longzhen Zhang · 2024 · Figshare
  80. Additional file 1 of Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer
    Qiaohua Wang, Wu, Yongjian, Jiang, Guanmin, Xi Huang · 2024 · Figshare
  81. Additional file 2 of Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
    Mei, Shenglin, Adele M. Alchahin, Ιωάννα Τσέα, Youmna Sami Kfoury, Taghreed Hirz, Nathan Elias Jeffries, Zhao, Ting, Yanxin Xu, Zhang, Hanyu, Sarkar, Hirak et al. · 2024 · Figshare
  82. Additional file 3 of HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling
    Hui Qiu, Shao, Zhiying, Wen, Xin, Debao Qu, Zhengyang Liu, Ziqin Chen, Zhang, Xinyan, Ding, Xin, Longzhen Zhang · 2024 · Figshare
  83. Diankuang Mengxing Decoction exerts neuroprotective effects in post-stroke depression by mediating the activation of the Wnt/β-catenin pathway via TREM2
    Xiuyan Yang, Yijing Zhao, Wei Liu, Jie Feng, Xiaoke Wu, Huan Ye, Yuan Xu, Chang Chen, Guojie Zhai · 2026 · Journal of Ethnopharmacology
  84. Single-cell dissection of pleural and systemic immunity uncovers pathogen-specific immune reprogramming in tuberculosis versus lung adenocarcinoma
    Sifei Yu, Yueming Liang, Jing Chen · 2026 · Inflammation Research
  85. Investigating the tumor-induced modifications of hematopoiesis during breast cancer
    Yohan Gerber-Ferder · 2022 · theses.fr (ABES)
  86. The role of CD74 in Treg biology : characterization of a newly identified tumor-associated Treg biomarker
    Elisa Bonnin · 2022 · theses.fr (ABES)
  87. The role of complement proteins on tumor progression : exploration of the universe of intracellular complement proteins
    Margot Revel · 2022 · theses.fr (ABES)
  88. Microenvironnement immunitaire du cancer de l'ovaire : évolution sous chimio/immunothérapie néoadjuvante, caractérisation de l'hétérogénéité et rôle des cellules sécrétrices d'anticorps
    Olivia Le Saux · 2022 · theses.fr (ABES)
  89. Characterizing and targeting the microenviromental changes in PIK3CA related overgrowth syndromes
    Ilaria Galasso · 2024 · theses.fr (ABES)
  90. From lipoprotein metabolism to blood clotting: Highlights of the 2025 Fredrickson lipid research conference
    Alexis Nicole Smith, Mirza A. Beg, Woosuk S. Hur, David Ginsburg, Iftikhar J. Kullo, Sean S. Davies, Ira A. Tabas, Jesse W. Williams, Chieko Mineo, Bishuang Cai et al. · 2026 · Journal of Lipid Research
  91. Role of monocytes, macrophages, and polymorphonuclear cells in cancer immunology
    Preeti Jain, Namita Panchal, Jacob Finley, Saurabh Kumar Gupta, Janvi Sandhu, Sadhna Aggarwal · 2026 · Elsevier eBooks
  92. Physiology, pathology and therapeutic potential of microglial triggering receptor expressed on myeloid cells 2 signalling: A narrative update
    Zhe Kong, Libin Shen, Daqing Ma, Jinchao Hou · 2026 · Clinical and Translational Discovery
  93. LGALS1 drives chemoresistance in esophageal squamous cell carcinoma by modulating epithelial-mesenchymal transition and tumor immunity
    Qi-Hang Yan, Chendi Xu, LI Zhen-guo, Yu-Zhen Zheng, Wing-Shing Wong, Da-chuan Liang, Jie Yang, Wu-Guang Chang, Jun-Ye Wang · 2026 · World Journal of Gastroenterology
  94. Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer Immunotherapy
    Zhiyuan Cheng, Jiacheng He, Changyao Li, Ke Quan, Limin Du, Xiaolei Chai, Xinyu Yang, Naijipu Abuduaini, Yuanyuan Fu, Jing Sun et al. · 2026 · Journal of Medicinal Chemistry
  95. Emerging concepts, hot topics, and open questions in today’s pancreatic cancer research
    Corinna Ulrike Keber, Mark Schmitt, Alexander Visekruna, Anna I. Brichkina, Elke Pogge von Strandmann, Jörg Walter Bartsch, Magdalena Huber, Uta‐Maria Bauer, Thomas Mathias Gress, Matthias Lauth · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  96. The evolving role of the immune microenvironment of tumor draining lymph nodes in the development of biomarkers of non-small cell lung cancer
    Zhan Hao Xi, Benjamin Zollinger, Yusuke Koga, Jason Weis, Joshua David Campbell, Sarah A. Mazzilli, Kei Suzuki · 2026 · Frontiers in Oncology
  97. TREM2-mediated recognition of candidalysin by macrophages confers early protective innate immunity in oropharyngeal candidiasis
    Weiwei Deng, Yishan Chen, Siqi Liu, Siqi Liu, Kai Zhang, Di Wang, Zhiying Yu, Weijia Zhao, Yingping Xu, Xiaowen Wang et al. · 2026 · Immunity & Inflammation
  98. Targeting PLD3 Reverses the Immunosuppressive Niche by Reprogramming Tumor‐Associated Macrophages and Potentiates Antitumor Immunity
    X H Qin, Qiong Li, Xuemei Xu, Yuhan Wu, Yin Zhu, Jieqiong Wu, Yuan Fang, Qiubei Chen, Song-hua Wang, Jiang Y et al. · 2026 · Advanced Science
  99. Hardwired and rewired: Tissue macrophages in homeostasis and cancer
    Hesham Mohei, Donn A. Van Deren, Malay Haldar · 2026 · Journal of Leukocyte Biology
  100. Plasma-derived exosomes from Graves’ orbitopathy: Pathogenic entities causing tissue lesions
    Zhihui Xu, Xiaoli Bao, Xi Wang et al. · 2026 · Experimental Eye Research